W L Gross
- Rheumatology top 2%
- Urticaria and Related Conditions 7
- Eosinophilic Disorders and Syndromes 3
- Rheumatoid Arthritis Research and Therapies 3
-
- Vasculitis and related conditions 15
- Nephrology top 5%
- Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
- Immunology and Allergy top 10%
-
- Mast cells and histamine 4
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Sarcoidosis and Beryllium Toxicity Research 3
- Co-authors
- Elena CsernokBernhard HellmichP A BaconJan Willem Cohen-TervaertOliver FloßmannPeter A. MerkelL GuillevinAlfred Mahr
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
W L Gross
26 papers receiving 812 citations
Peers
Comparison fields: 5 of 59
- Rheumatology 363
- Pulmonary and Respiratory Medicine 691
- Nephrology 102
- Genetics 151
- Immunology and Allergy 61
Countries citing papers authored by W L Gross
This map shows the geographic impact of W L Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W L Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W L Gross more than expected).
Fields of papers citing papers by W L Gross
This network shows the impact of papers produced by W L Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W L Gross. The network helps show where W L Gross may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W L Gross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 40 | |
| 2 | Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis. | 2009 | 24 |
| 3 | 2008 | 0 | |
| 4 | 2008 | 15 | |
| 5 | 2008 | 23 | |
| 6 | 2007 | 3 | |
| 7 | Current knowledge on cellular interactions in the WG-granuloma. | 2007 | 19 |
| 8 | 2006 | 454 | |
| 9 | Immune phenomena in localized and generalized Wegener's granulomatosis. | 2004 | 10 |
| 10 | Update on the pathogenesis of Churg-Strauss syndrome. | 2004 | 45 |
| 11 | 2002 | 2 | |
| 12 | 2000 | 18 | |
| 13 | 1999 | 42 | |
| 14 | Elevated procalcitonin levels in active Wegener's granulomatosis. | 1998 | 49 |
| 15 | [Methotrexate therapy of inflammatory diseases. Reliable effects and recent developments in rheumatology, pneumology, gastroenterology and dermatology]. | 1995 | 3 |
| 16 | 1993 | 7 | |
| 17 | 1991 | 4 | |
| 18 | 1988 | 2 | |
| 19 | [Lyme borreliosis in northern Germany]. | 1988 | 1 |
| 20 | 1979 | 1 |
About W L Gross
W L Gross is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Genetics, having authored 27 papers that have together received 841 indexed citations. Recurring topics across this work include Vasculitis and related conditions (15 papers), Urticaria and Related Conditions (7 papers), Mast cells and histamine (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Eosinophilic Disorders and Syndromes (3 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). The work is most often cited by research in Rheumatology (363 citations), Pulmonary and Respiratory Medicine (691 citations) and Nephrology (102 citations). W L Gross has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Elena Csernok, Bernhard Hellmich, Elena Csernok, P A Bacon, Jan Willem Cohen-Tervaert, Oliver Floßmann, Peter A. Merkel, L Guillevin, Alfred Mahr and David Jayne. Their work appears in journals such as The Lancet, Annals of the Rheumatic Diseases and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.